Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Skip to main content
Phase: II/III
Status: Not Recruiting
The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.
Principal Investigator
James Joye, DO
Sponsor
Medtronic Cardiovascular
NCT Number
NCT01586910
Contact
Kara Turner, Clinical Research Coordinator
Taft Center for Clinical Research
650-962-4562
kara_turner@elcaminohealth.org
For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.